Treatment of Inoperable Stage III and IV Non-Small-Cell Lung Cancer: The ‘Average’Radiotherapist’s Point of View

Publisher： Karger

E-ISSN： 2296-5262|24|4|333-339

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.24, Iss.4, 2001-09, pp. : 333-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extra-cranial Stereotactic Radiation Therapy (ESRT) in the treatment of inoperable stage 1 2 non-small-cell lung cancer patients with highly mobile tumours: a literature review

By  

Journal of Radiotherapy in Practice, Vol. 9, Iss. 4, 2010-11 ,pp. : 247-259

Cambridge University Press

Access to resources Recommend Favorite

Concurrent Radiochemotherapy with Ifosfamide in Unresectable Stage III Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 1, 1998-03 ,pp. : 57-62

Karger

Access to resources Recommend Favorite

Predicting Chemotherapy Response to Paclitaxel-Based Therapy in Advanced Non-Small-Cell Lung Cancer (Stage IIIb or IV) with a Higher T Stage (> T2)

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 173-179

Karger

Access to resources Recommend Favorite

A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-07 ,pp. : 435-443

Karger

Access to resources Recommend Favorite

Stereotactic body radiation therapy versus no treatment for early stage non–small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4222-4230

John Wiley & Sons Inc

Access to resources Recommend Favorite